News
TXTM
0.0036
+2.86%
0.0001
Weekly Report: what happened at TXTM last week (0831-0904)?
Weekly Report · 2d ago
Weekly Report: what happened at TXTM last week (0824-0828)?
Weekly Report · 08/31 10:02
Weekly Report: what happened at TXTM last week (0817-0821)?
Weekly Report · 08/24 10:02
Weekly Report: what happened at TXTM last week (0810-0814)?
Weekly Report · 08/17 10:03
Weekly Report: what happened at TXTM last week (0803-0807)?
Weekly Report · 08/10 09:59
Weekly Report: what happened at TXTM last week (0727-0731)?
Weekly Report · 08/03 09:59
Weekly Report: what happened at TXTM last week (0720-0724)?
Weekly Report · 07/27 10:02
Weekly Report: what happened at TXTM last week (0713-0717)?
Weekly Report · 07/20 09:59
Weekly Report: what happened at TXTM last week (0706-0710)?
Weekly Report · 07/13 10:01
Weekly Report: what happened at TXTM last week (0629-0703)?
Weekly Report · 07/06 10:04
Weekly Report: what happened at TXTM last week (0622-0626)?
Weekly Report · 06/29 10:00
Weekly Report: what happened at TXTM last week (0615-0619)?
Weekly Report · 06/22 10:07
ProText Mobility Launches New Website and Investor Platform
TipRanks · 06/15 16:59
Weekly Report: what happened at TXTM last week (0608-0612)?
Weekly Report · 06/15 10:08
Weekly Report: what happened at TXTM last week (0601-0605)?
Weekly Report · 06/08 10:04
Weekly Report: what happened at TXTM last week (0525-0529)?
Weekly Report · 06/01 10:08
Weekly Report: what happened at TXTM last week (0518-0522)?
Weekly Report · 05/25 10:10
Weekly Report: what happened at TXTM last week (0511-0515)?
Weekly Report · 05/18 10:10
Weekly Report: what happened at TXTM last week (0504-0508)?
Weekly Report · 05/11 10:08
Weekly Report: what happened at TXTM last week (0427-0501)?
Weekly Report · 05/04 10:06
More
Webull provides a variety of real-time TXTM stock news. You can receive the latest news about Protext Mobility Inc through multiple platforms. This information may help you make smarter investment decisions.
About TXTM
Protext Mobility, Inc. is a biotech company developing a hemp/cannabidiol (CBD) - cannabis medicines platform for the legal cannabis industry, using live plant extraction processes and technologies. The Company engages in the research, testing and development of bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications using proprietary live plant extraction technology. The Company's subsidiaries include Plandai Biotechnology, Cannabis Biosciences, Inc., and RSAMMD Acquisitions LLC.